BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bou-Dargham MJ, Liu Y, Sang QA, Zhang J. Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3. PLoS One 2018;13:e0207799. [PMID: 30513096 DOI: 10.1371/journal.pone.0207799] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Bou-Dargham MJ, Draughon S, Cantrell V, Khamis ZI, Sang QA. Advancements in Human Breast Cancer Targeted Therapy and Immunotherapy. J Cancer 2021;12:6949-63. [PMID: 34729098 DOI: 10.7150/jca.64205] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
2 Dastmalchi N, Safaralizadeh R, Latifi-Navid S, Banan Khojasteh SM, Mahmud Hussen B, Teimourian S. An updated review of the role of lncRNAs and their contribution in various molecular subtypes of breast cancer. Expert Rev Mol Diagn 2021;:1-12. [PMID: 34334086 DOI: 10.1080/14737159.2021.1962707] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Rajagopal T, Talluri S, Venkatabalasubramanian S, Dunna NR. Multifaceted roles of long non-coding RNAs in triple-negative breast cancer: biology and clinical applications. Biochem Soc Trans 2020;48:2791-810. [PMID: 33258920 DOI: 10.1042/BST20200666] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Lankipalli S, Ramagopal UA. A structural perspective on the design of decoy immune modulators. Pharmacol Res 2021;170:105735. [PMID: 34146695 DOI: 10.1016/j.phrs.2021.105735] [Reference Citation Analysis]
5 Thakur KK, Kumar A, Banik K, Verma E, Khatoon E, Harsha C, Sethi G, Gupta SC, Kunnumakkara AB. Long noncoding RNAs in triple-negative breast cancer: A new frontier in the regulation of tumorigenesis. J Cell Physiol 2021. [PMID: 34105151 DOI: 10.1002/jcp.30463] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 20.0] [Reference Citation Analysis]
6 Chen X, School of Basic Education, Changsha Aeronautical Vocational and Technical College, Changsha, Hunan 410124, China, Lin Y, Qu Q, Ning B, Chen H, Li X, College of Computer Science and Electronic Engineering, Hunan University, Changsha, Hunan 410082, China, School of Software, East China Jiaotong University, Nanchang 330013, China. An epistasis and heterogeneity analysis method based on maximum correlation and maximum consistence criteria. MBE 2021;18:7711-7726. [DOI: 10.3934/mbe.2021382] [Reference Citation Analysis]
7 Chen X, Lin Y, Qu Q, Ning B, Chen H, Cai L. A Multi-Source Data Fusion Framework for Revealing the Regulatory Mechanism of Breast Cancer Immune Evasion. Front Genet 2020;11:595324. [PMID: 33304391 DOI: 10.3389/fgene.2020.595324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Gu X, Mao Z, Pan H, Zou C, Ding G, Fan Y. <p>Case–Control Study on <em>TNFRSF6B</em> Gene Polymorphism and Susceptibility to Gastric Cancer in a Chinese Han Population</p>. PGPM 2020;Volume 13:749-756. [DOI: 10.2147/pgpm.s283308] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Qu J, Steppi A, Zhong D, Hao J, Wang J, Lung PY, Zhao T, He Z, Zhang J. Triage of documents containing protein interactions affected by mutations using an NLP based machine learning approach. BMC Genomics 2020;21:773. [PMID: 33167858 DOI: 10.1186/s12864-020-07185-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Lung PY, Zhong D, Pang X, Li Y, Zhang J. Maximizing the reusability of gene expression data by predicting missing metadata. PLoS Comput Biol 2020;16:e1007450. [PMID: 33156882 DOI: 10.1371/journal.pcbi.1007450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Leung KL, Verma D, Azam YJ, Bakker E. The use of multi-omics data and approaches in breast cancer immunotherapy: a review. Future Oncol 2020;16:2101-19. [PMID: 32857605 DOI: 10.2217/fon-2020-0143] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Kansara S, Pandey V, Lobie PE, Sethi G, Garg M, Pandey AK. Mechanistic Involvement of Long Non-Coding RNAs in Oncotherapeutics Resistance in Triple-Negative Breast Cancer. Cells 2020;9:E1511. [PMID: 32575858 DOI: 10.3390/cells9061511] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 22.5] [Reference Citation Analysis]
13 Bou-Dargham MJ, Sha L, Sang QA, Zhang J. Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy. BMC Cancer 2020;20:572. [PMID: 32552802 DOI: 10.1186/s12885-020-07058-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
14 [DOI: 10.1101/828145] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Reference Citation Analysis]